BVCF Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 15
Professionals
  • Investments
  • 59
  • Portfolio
  • 25
  • Exits
  • 28
Exits

BVCF General Information

Description

BVCF is a venture capital firm founded in 2005 that focuses on life sciences and healthcare sectors in China. The firm invests across China and the United States including healthcare services, innovative biologic, in-vitro diagnostics (molecular diagnostics), high value medical equipment and consumables and medical big data and mobile medicine.

Contact Information

Website
www.bvcf.com
Formerly Known As
BioVeda China Fund
Year Founded
2005
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
  • 763 Mengzi Road
  • Suite 2606
  • Shanghai, 200023
  • China
+86 021 0000 0000

BVCF Investments (59)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Oculis 01-Dec-2021 Later Stage VC 00.000 Drug Discovery Clinical Trials - Phase 2
000000000 04-Nov-2021 00000 00000 0000 Drug Discovery Clinical Trials - Phase 1 000 0000 00.0
000000 28-Apr-2021 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 2 000 0000 00.0
000000 24-Feb-2021 00000 00000 Clinics/Outpatient Services Generating Revenue
0000 0000 09-Feb-2021 00000 00000 0000 Biotechnology Clinical Trials - Phase 1
0000 0000000 26-Jan-2021 00 000000000 0000 Drug Discovery Profitable
0000 000000000 07-Jan-2021 00000 00000 Drug Discovery Clinical Trials - General
000000000 00000000 04-Jan-2021 00000 00000 000.00 Drug Discovery Clinical Trials - General
MicuRx Pharmaceuticals 20-Oct-2020 Secondary Transaction - Private 000.00 Pharmaceuticals Generating Revenue 00000 0000
Seinda 23-Sep-2020 Later Stage VC Diagnostic Equipment Generating Revenue
You’re viewing 10 of 59 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BVCF Exits (28)

Company Name Exit Date Exit Type Exit Size
Clarus Therapeutics 09-Sep-2021 Reverse Merger 000.00
0000000 0000000000 17-Jun-2021 000 00000
0000000 21-May-2021 000 000.00
000000 29-Jan-2021 00 000000000000000 000.00
000000000 15-Jan-2021 000 00000
0000000000 20-Oct-2020 000000000 00000000 000.00
000000 000000000 24-Sep-2020 000000000000000000
000000 0000000000 12-Aug-2020 000 00000
BioNTech 10-Oct-2019 IPO 00000
Stealth BioTherapeutics 15-Feb-2019 IPO 0000
You’re viewing 10 of 28 exits. Get the full list »

BVCF Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore BVCF‘s full profile, request access.

Request a free trial

BVCF Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

BVCF Team (16)

Name Title Deals Funds Boards Office
Mengqi Chen Chief Financial Officer Shanghai, China
Davis Yang Managing Director 0 0 0 Shanghai, China
Bing Zhuo Partner & Head of Beijing Office 0 0 0 Shanghai, China
Hong Lin Partner Shanghai, China
Yi Li Ph.D Partner Shanghai, China
You’re viewing 5 of 16 team members. Get the full list »